Sustained statin use is associated with lower risk of death in lung cancer patients, study showsBMJ 2015; 350 doi: https://doi.org/10.1136/bmj.h2382 (Published 01 May 2015) Cite this as: BMJ 2015;350:h2382
- Susan Mayor
Patients with lung cancer who have had more than 12 prescriptions for statins after their cancer diagnosis have a significantly lower risk of death from the disease than lung cancer patients who don’t take these commonly prescribed drugs, concludes a study that researchers say supports further investigation into the use of statins as adjuvant cancer therapy.
The study, published in Cancer Epidemiology, Biomarkers & Prevention, identified 14 689 patients in the English cancer registry who had been given a …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial